Literature DB >> 14685825

Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients.

Yuichi Uwai1, Satohiro Masuda1, Maki Goto1, Hideyuki Motohashi1, Hideyuki Saito1, Masahiro Okuda1, Eijirou Nakamura2, Noriyuki Ito2, Osamu Ogawa2, Ken-Ichi Inui3.   

Abstract

In this study, we have quantified the mRNA expression levels of multidrug resistance gene 1 (MDR1) in the normal kidney cortex and renal cell carcinoma (RCC) segments from 24 Japanese nephrectomized patients by real-time polymerase chain reaction (PCR). The mRNA expression level of MDR1 in RCC segments was significantly decreased in comparison with each normal segment (P=0.0042, by Student's paired t-test). In addition, the ten common single nucleotide polymorphisms (SNPs) of the MDR1 gene in the patients were assessed using the PCR-restriction enzyme fragment length polymorphism method to investigate the influence of these SNPs on its mRNA expression levels. The allele frequencies of these SNPs were comparable with our previous report in the Japanese recipients of living-donor liver transplantation (Goto et al., Pharmacogenetics 12:451-457; 2002). MDR1 expression levels in the normal kidney cortex were independent on the five SNPs, which were polymorphic in the Japanese population. Furthermore, the effect of the SNPs on expression levels of MDR1 mRNA in RCC segments was not recognized. These findings suggest that the common SNPs in the MDR1 gene have no influence on the expression of its transcript in RCC segments as well as in the normal kidney cortex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14685825     DOI: 10.1007/s10038-003-0105-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  24 in total

1.  Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance.

Authors:  Y Kakehi; H Kanamaru; O Yoshida; H Ohkubo; S Nakanishi; M M Gottesman; I Pastan
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

2.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

3.  Frequency of C3435T polymorphism of MDR1 gene in African people.

Authors:  E Schaeffeler; M Eichelbaum; U Brinkmann; A Penger; S Asante-Poku; U M Zanger; M Schwab
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

4.  Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.

Authors:  E G Schuetz; K N Furuya; J D Schuetz
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

5.  Single nucleotide polymorphisms of estrogen receptor alpha in human renal cell carcinoma.

Authors:  Yuichiro Tanaka; Masahiro Sasaki; Masanori Kaneuchi; Seiichiro Fujimoto; Rajvir Dahiya
Journal:  Biochem Biophys Res Commun       Date:  2002-09-06       Impact factor: 3.575

6.  MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males.

Authors:  Thomas Gerloff; Melanie Schaefer; Andreas Johne; Kersti Oselin; Christian Meisel; Ingolf Cascorbi; Ivar Roots
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

7.  Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP),glutathione-S-transferase-pi (GST-pi) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney.

Authors:  W J Kim; Y Kakehi; H Kinoshita; S Arao; M Fukumoto; O Yoshida
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

8.  Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors.

Authors:  Michael Siegsmund; Ulrich Brinkmann; Elke Scháffeler; Gregor Weirich; Matthias Schwab; Michel Eichelbaum; Peter Fritz; Oliver Burk; Jochen Decker; Peter Alken; Uwe Rothenpieler; Reinhold Kerb; Sven Hoffmeyer; Hiltrud Brauch
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

9.  Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

Authors:  Yasuo Kurata; Ichiro Ieiri; Miyuki Kimura; Toshihiro Morita; Shin Irie; Akinori Urae; Shigehiro Ohdo; Hisakazu Ohtani; Yasufumi Sawada; Shun Higuchi; Kenji Otsubo
Journal:  Clin Pharmacol Ther       Date:  2002-08       Impact factor: 6.875

10.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

Authors:  S Hoffmeyer; O Burk; O von Richter; H P Arnold; J Brockmöller; A Johne; I Cascorbi; T Gerloff; I Roots; M Eichelbaum; U Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  7 in total

1.  MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.

Authors:  Xiaojing Sheng; Limei Zhang; Na Tong; Dewei Luo; Meilin Wang; Min Xu; Zhengdong Zhang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 2.  Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.

Authors:  Stefan Wolking; Elke Schaeffeler; Holger Lerche; Matthias Schwab; Anne T Nies
Journal:  Clin Pharmacokinet       Date:  2015-07       Impact factor: 6.447

3.  MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case-control studies.

Authors:  Jun Wang; Baocheng Wang; Jingwang Bi; Kainan Li; Jianshi Di
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-23       Impact factor: 4.553

4.  Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers.

Authors:  Mari Jiko; Ikuko Yano; Eriko Sato; Kazushige Takahashi; Hideyuki Motohashi; Satohiro Masuda; Masahiro Okuda; Noriyuki Ito; Eijiro Nakamura; Takehiko Segawa; Toshiyuki Kamoto; Osamu Ogawa; Ken-Ichi Inui
Journal:  Int J Clin Oncol       Date:  2007-08-20       Impact factor: 3.402

5.  Gene-wide characterization of common quantitative trait loci for ABCB1 mRNA expression in normal liver tissues in the Chinese population.

Authors:  Weihua Shou; Dazhi Wang; Kaiyue Zhang; Beilan Wang; Zhimin Wang; Jinxiu Shi; Wei Huang
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

6.  Corpora amylacea deposition in the hippocampus of patients with mesial temporal lobe epilepsy: A new role for an old gene?

Authors:  Abhijit Das; Shabeesh Balan; Anila Mathew; Venkataraman Radhakrishnan; Moinak Banerjee; Kurupath Radhakrishnan
Journal:  Indian J Hum Genet       Date:  2011-05

7.  CYP3A5 Genotype as a Potential Pharmacodynamic Biomarker for Tacrolimus Therapy in Ulcerative Colitis in Japanese Patients.

Authors:  Yuki Yamamoto; Hiroshi Nakase; Minoru Matsuura; Shihoko Maruyama; Satohiro Masuda
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.